Literature DB >> 32336414

Blastic Plasmacytoid Dendritic Cell Neoplasm: Clinical Presentation and Diagnosis.

Eric Deconinck1, Tony Petrella2, Francine Garnache Ottou3.   

Abstract

Clinical and biological presentation of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN) is depicted to highlight criteria that might alert physicians. Diagnosis of BPDCN is still challenging and requires (1) immunophenotyping of blood or bone marrow aspiration using several markers (CD4, CD56, HLA-DR, myeloid and lymphoid lineage markers) and should include pDC markers such as CD123, cTCL1, CD303, and CD304, and/or (2) pathologic analysis of cutaneous lesions, also with immunohistochemistry using markers specific to BPDCN. Crown
Copyright © 2020. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anatomopathology; BPDCN; Clinical presentation; Diagnosis; Immunophenotyping; Morphologies

Year:  2020        PMID： 32336414     DOI： 10.1016/j.hoc.2020.01.010

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN： 0889-8588            Impact factor:   3.722


  6 in total

1.  Sex-Biased ZRSR2 Mutations in Myeloid Malignancies Impair Plasmacytoid Dendritic Cell Activation and Apoptosis.

Authors:  Katsuhiro Togami; Sun Sook Chung; Vikas Madan; Christopher A G Booth; Christopher M Kenyon; Lucia Cabal-Hierro; Justin Taylor; Sunhee S Kim; Gabriel K Griffin; Mahmoud Ghandi; Jia Li; Yvonne Y Li; Fanny Angelot-Delettre; Sabeha Biichle; Michael Seiler; Silvia Buonamici; Scott B Lovitch; Abner Louissaint; Elizabeth A Morgan; Fabrice Jardin; Pier Paolo Piccaluga; David M Weinstock; Peter S Hammerman; Henry Yang; Marina Konopleva; Naveen Pemmaraju; Francine Garnache-Ottou; Omar Abdel-Wahab; H Phillip Koeffler; Andrew A Lane
Journal:  Cancer Discov       Date:  2021-10-06       Impact factor: 38.272

2.  Localized skin-limited blastic plasmacytoid dendritic cell neoplasm.

Authors:  Edwin U Suárez; Javier Cornago; Miguel Á Piris; Socorro M Rodriguez Pinilla; José L López-Lorenzo; Carlos Soto
Journal:  EJHaem       Date:  2022-03-01

3.  Allogeneic hematopoietic cell transplantation for patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN).

Authors:  Qaiser Bashir; Denái R Milton; Uday R Popat; Partow Kebriaei; Chitra Hosing; Issa F Khouri; Katayoun Rezvani; Yago Nieto; Betul Oran; Samer A Srour; Neeraj Y Saini; Amanda L Olson; Sairah Ahmed; Gheath Al-Atrash; Gabriela Rondon; Marina Y Konopleva; Richard E Champlin; Elizabeth J Shpall; Muzaffar H Qazilbash; Naveen Pemmaraju
Journal:  Bone Marrow Transplant       Date:  2021-10-11       Impact factor: 5.174

4.  E-Cadherin Expression and Blunted Interferon Response in Blastic Plasmacytoid Dendritic Cell Neoplasm.

Authors:  Luisa Lorenzi; Silvia Lonardi; Donatella Vairo; Andrea Bernardelli; Michela Tomaselli; Mattia Bugatti; Sara Licini; Mariachiara Arisi; Lorenzo Cerroni; Alessandra Tucci; William Vermi; Silvia Clara Giliani; Fabio Facchetti
Journal:  Am J Surg Pathol       Date:  2021-10-01       Impact factor: 6.298

5.  Blastic Plasmacytoid Dendritic Cell Neoplasm With Central Nervous System Involvement: A Case Report.

Authors:  Diego Molina Castro; Oliver Perilla Suárez; Jorge Cuervo-Sierra; Alexandra Moreno
Journal:  Cureus       Date:  2022-04-06

Review 6.  Clinical Insights into the Management of Blastic Plasmacytoid Dendritic Cell Neoplasm.

Authors:  Yumeng Zhang; Lubomir Sokol
Journal:  Cancer Manag Res       Date:  2022-06-28       Impact factor: 3.602
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.